Researchers Developed Advanced Antimicrobial Dressings
The AntiMicroMXen project combines electrospun membranes with bacteriophages to treat chronic wounds.
Updated on Oct. 1, 2026 in Materials Science
Live Poll
Should medical researchers prioritize developing natural alternatives to treat infections over traditional antibiotic treatments?
Initiated in June 2024, the AntiMicroMXen project explores the use of electrospun fabric membranes to improve chronic wound care. The initiative integrates antibacterial bacteriophages, proteins, and MXenes to create dressings that address antibiotic resistance and encourage skin cell regeneration.
Why it matters
By providing a targeted antimicrobial solution, these dressings aim to accelerate recovery for patients with complex conditions like diabetes. The project seeks to alleviate the significant medical and financial burden currently associated with chronic wound management.
Researchers use electrospinning to create fabric membranes from polymer solutions in an electric field. This process embeds bacteriophages, which are sourced from laboratory cultures or hospital wastewater, into the material to create active antimicrobial properties.
The players
Fraunhofer Institute for Ceramic Technologies and Systems IKTS
This German research organization focuses on ceramic materials and systems to drive industrial innovation.
Hirszfeld Institute of Immunology and Experimental Therapy
Based in Poland, this institute conducts advanced research in immunology and the therapeutic use of bacteriophages.
University of Latvia
This public research university in Riga contributes academic expertise to international scientific collaborations.
NanoCarbonTech
This company specializes in the development and application of carbon-based nanomaterials in technological products.
The details
The project involves an international collaboration between the Fraunhofer Institute for Ceramic Technologies and Systems IKTS, the Hirszfeld Institute of Immunology and Experimental Therapy, the University of Latvia, and NanoCarbonTech. These specialized membranes leverage the unique properties of MXenes to ensure the sustained release of therapeutic proteins directly into the wound site.
Timeline
The AntiMicroMXen project commenced in June 2024.
The development of materials and active ingredients is scheduled for completion in May 2027.
Deeper Dive
The AntiMicroMXen project is supported by the M-ERA.NET research funding network, which fosters international cooperation in materials science. This collaborative model reflects a broader shift toward integrating complex biological components into industrial textile manufacturing.
This development could eventually lead to faster, more effective clinical treatment options for patients suffering from long-term diabetic ulcers. By reducing the reliance on traditional systemic antibiotics, these dressings may decrease the risk of complications from antibiotic-resistant infections.
The takeaway
Chronic wound treatment represents a significant global medical challenge that requires sophisticated material solutions. These antimicrobial dressings highlight how integrating biological agents with synthetic fibers can provide a path to more effective wound management.
What happens next
The development and integration of all active ingredients into the wound dressing materials are projected to be completed by May 2027.
Further reading
Learn more about the latest innovations in this field in our Materials Science section.
More information
Review the full project scope in the Fraunhofer research project information.
Source note: This article includes information reported by Informationdienst Wissenschaft e.V. - idw.
Live Poll
Should medical researchers prioritize developing natural alternatives to treat infections over traditional antibiotic treatments?
